Noah R. Wolkowicz , Suprit Parida , Ralitza Gueorguieva , Mehmet Sofuoglu
{"title":"Switching from menthol to non-menthol cigarettes does not impact acute responses to intravenous nicotine","authors":"Noah R. Wolkowicz , Suprit Parida , Ralitza Gueorguieva , Mehmet Sofuoglu","doi":"10.1016/j.pbb.2025.173985","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Limited research exists on how switching from menthol to non-menthol cigarettes affects the acute response to nicotine for individuals who smoke menthol cigarettes. Such research can inform public health strategies to reduce smoking prevalence.</div></div><div><h3>Aims</h3><div>This study investigated whether switching from menthol to non-menthol cigarettes for two weeks alters the acute responses to intravenous nicotine infusions delivered at different rates. We assessed changes in subjective drug effects, smoking urges, withdrawal severity, heart rate, and performance on the Continuous Performance Test (CPT) (primary outcomes); as well as nicotine biomarker blood levels (ng/ml) of nicotine, cotinine, and nicotine metabolite ratio (NMR; hydroxycotinine/cotinine), and cigarette consumption (secondary outcomes).</div></div><div><h3>Methods</h3><div>Sixteen menthol-preferring individuals who smoke cigarettes were randomized to a sequence of menthol or non-menthol cigarette smoking conditions for 2 weeks (Phase 1) and then switched to the other condition for another 2 weeks (Phase 2). During week 2 of each phase, an experimental session was held. During the experimental sessions, participants were given a total of 3 infusions, one saline and two nicotine infusions delivered at different rates (1 mg nicotine delivered over 2.5- and 5-min). Each infusion period lasted 10 min, with saline administered for the remainder of the time after the 2.5- and 5-min nicotine infusions. Following the first session, participants crossed over to the other smoking condition.</div></div><div><h3>Results</h3><div>Switching to non-menthol cigarettes led to a decrease in daily cigarette smoking (<em>p</em> < .05). However, this switch did not appear to affect the severity of tobacco withdrawal, urges to smoke, or the subjective and heart rate responses to IV nicotine administration (<em>p</em> > .05).</div></div><div><h3>Conclusions</h3><div>These findings suggest that switching from menthol to non-menthol cigarettes is feasible without significantly altering the individual's response to nicotine. Further, there may be a potential public health benefit through reduced cigarette consumption.</div></div>","PeriodicalId":19893,"journal":{"name":"Pharmacology Biochemistry and Behavior","volume":"249 ","pages":"Article 173985"},"PeriodicalIF":3.3000,"publicationDate":"2025-02-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pharmacology Biochemistry and Behavior","FirstCategoryId":"102","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0091305725000322","RegionNum":3,"RegionCategory":"心理学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"BEHAVIORAL SCIENCES","Score":null,"Total":0}
引用次数: 0
Abstract
Background
Limited research exists on how switching from menthol to non-menthol cigarettes affects the acute response to nicotine for individuals who smoke menthol cigarettes. Such research can inform public health strategies to reduce smoking prevalence.
Aims
This study investigated whether switching from menthol to non-menthol cigarettes for two weeks alters the acute responses to intravenous nicotine infusions delivered at different rates. We assessed changes in subjective drug effects, smoking urges, withdrawal severity, heart rate, and performance on the Continuous Performance Test (CPT) (primary outcomes); as well as nicotine biomarker blood levels (ng/ml) of nicotine, cotinine, and nicotine metabolite ratio (NMR; hydroxycotinine/cotinine), and cigarette consumption (secondary outcomes).
Methods
Sixteen menthol-preferring individuals who smoke cigarettes were randomized to a sequence of menthol or non-menthol cigarette smoking conditions for 2 weeks (Phase 1) and then switched to the other condition for another 2 weeks (Phase 2). During week 2 of each phase, an experimental session was held. During the experimental sessions, participants were given a total of 3 infusions, one saline and two nicotine infusions delivered at different rates (1 mg nicotine delivered over 2.5- and 5-min). Each infusion period lasted 10 min, with saline administered for the remainder of the time after the 2.5- and 5-min nicotine infusions. Following the first session, participants crossed over to the other smoking condition.
Results
Switching to non-menthol cigarettes led to a decrease in daily cigarette smoking (p < .05). However, this switch did not appear to affect the severity of tobacco withdrawal, urges to smoke, or the subjective and heart rate responses to IV nicotine administration (p > .05).
Conclusions
These findings suggest that switching from menthol to non-menthol cigarettes is feasible without significantly altering the individual's response to nicotine. Further, there may be a potential public health benefit through reduced cigarette consumption.
期刊介绍:
Pharmacology Biochemistry & Behavior publishes original reports in the areas of pharmacology and biochemistry in which the primary emphasis and theoretical context are behavioral. Contributions may involve clinical, preclinical, or basic research. Purely biochemical or toxicology studies will not be published. Papers describing the behavioral effects of novel drugs in models of psychiatric, neurological and cognitive disorders, and central pain must include a positive control unless the paper is on a disease where such a drug is not available yet. Papers focusing on physiological processes (e.g., peripheral pain mechanisms, body temperature regulation, seizure activity) are not accepted as we would like to retain the focus of Pharmacology Biochemistry & Behavior on behavior and its interaction with the biochemistry and neurochemistry of the central nervous system. Papers describing the effects of plant materials are generally not considered, unless the active ingredients are studied, the extraction method is well described, the doses tested are known, and clear and definite experimental evidence on the mechanism of action of the active ingredients is provided.